International Journal of Clinical Microbiology

International Journal of Clinical Microbiology

Current Issue Volume No: 1 Issue No: 1

Research-article Article Open Access
  • Available online freely Peer Reviewed
  • The Development And Evaluation Of A Multiplex Real-Time PCR Assay For The Detection Of ESBL Genes In Urinary Tract Infections

    Reid Ruth 1     Samaras Shivanthi 1
       

    1 Molecular Microbiology, School of Allied Health Sciences, Faculty of Health & Life Sciences, Hawthorn Building, The Gateway, De Montfort University, Leicester, LE1 9BH United Kingdom 

    Abstract

    Background

    Overuse of beta-lactam antibiotics has lead to selection for extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae, a major cause of antibiotic resistant urinary tract infections (UTIs). Standard detection methods are time-consuming, with disputed accuracy.

    This study describes a novel real-time PCR method to detect CTX-M, SHV, OXA and TEM.

    Methods

    179 Enterobacteriaceae isolates from UTIs were collected from the Leicester Royal Infirmary, UK. A multiplex Plexor®-based real-time PCR assay detected ESBLs using their specific amplicon melting temperature, during each cycle, removing the need for a melt-curve analysis. Validation was achieved by end-point PCR and disk diffusion.

    Results

    The method was able to produce rapid and accurate results, achieving a sensitivity and specificity of 94.9% and 72% respectively, and the assay can differentiate between the different ESBL genes, with ease.

    Conclusions

    With further investigation, a Plexor®-based assay could form the basis of a high-throughput kit that health services could use to detect ESBLs or other antibiotic resistance genes.

    Author Contributions
    Received Jul 10, 2018     Accepted Aug 06, 2018     Published Aug 09, 2018

    Copyright© 2018 Reid Ruth, et al.
    License
    Creative Commons License   This work is licensed under a Creative Commons Attribution 4.0 International License. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

    Competing interests

    The authors have declared that no competing interests exist.

    Funding Interests:

    Citation:

    Reid Ruth, Samaras Shivanthi (2018) The Development And Evaluation Of A Multiplex Real-Time PCR Assay For The Detection Of ESBL Genes In Urinary Tract Infections International Journal of Clinical Microbiology. - 1(1):16-24
    DOI 10.14302/issn.2690-4721.ijcm-18-2217

    Introduction

    Introduction

    Antibiotic resistance is a natural process, whereby bacteria exchange genes via horizontal transfer, however the overuse of antibiotics has caused a permanent selective force for resistance mechanisms. 1 In the O’Neill report in 2016, it was estimated that every year at least 700,000 people die as a result of antibiotic resistant infections. 2

    Extended-spectrum β-lactamases (ESBLs) are one of the most common types of antibiotic resistance found in Enterobacteriaceae and are a major public health concern, both in hospital settings and in the community. 34 First discovered in the 1980’s, ESBLs have since increased massively, becoming a major public concern. 1

    ESBLs are able to hydrolyze extended - spectrum cephalosporins (cefotaxime, ceftriaxone, ceftazidime and cefepime) and monobactams (aztreonam). 45 The most common families of ESBLs found are CTX-M, SHV, OXA and TEM. 1

    Urinary tract infections (UTIs) are the most common infection found in humans. 6The majority of both community-acquired and nosocomial UTIs are caused by uropathogenic Escherichia coli (UPEC) strains. 6 Serious infection by ESBL-producing UPEC can be linked to increased length of hospital stay, admittance to an intensive care unit, catheterization, increased mortality, morbidity and healthcare cost. 7489 Therefore, early detection would benefit both the patient and the health care provider. Screening for ESBL-producing uropathogens is commonly achieved by means of selective agar plates, such as the commercially available ESBL agar. Isolates are also tested for antibiotic sensitivity by disk diffusion or broth microdilution. 5 These procedures can take 4-6 days to obtain an antibiotic resistance profile after the culture, isolation and characterisation of pathogens from a patient sample.

    In the O’Neill report, it was suggested that rapid diagnosis could change the way we use antibiotics. Reducing the time spent on broad-spectrum antibiotics by prescribing a more appropriate treatment, increases the favorability of the outcome of the patient and shortens the stay in hospital. Rapid detection of ESBL isolates also has other benefits, including infection control and prevention of outbreaks through the use of hospital hygiene precaution measures. 71011 Therefore, rapid and sensitive detection of infections thought to be of the ESBL type is of the utmost importance for patient outcome, the economy and outbreak control.

    In this study, a multiplex real-time assay was developed and validated to detect the most prevalent ESBL-producing genes in bacterial isolates found in UTIs, based on the amplicon melting temperature.

    Results

    Results

    A Plexor®-based multiplex real-time PCR assay was designed to simultaneously detect the ESBL genes CTX-M, TEM, OXA and SHV, using amplicon melting temperatures, without the use of melting curve analysis. Figure 2 shows the results of the development of the real-time PCR method Table 1.

    Primers used in this study.
    Oligo Forward Reverse Reference
    OXA 48 AGCAAAGGAATGGCAAGAAA CGCCCTGTGATTTATGTTCA 12
    SHV GGTCAGCGAAAAACAYCTTG GCCTCATTCAGTTCCGTTTC 12
    TEM GATACGGGAGGGCTTACCAT GGATGGAGGCGGATAAAGTT 12
    CTX-M AATCTGACGCTGGGTAAAG  CCGCTGCCGGTTTTATC 12
    Data showing the change in fluorescence at cycle 16-31 (when florescence) at low temperature and at the meeting of each amplicon. Data was normalized to the highest relative fluorescent unit (RFU). At temperature below the Tm, fluorescence decreases as product Increases each cycle. This is due to the Incorporation of the Dabcyl-iso-dGTP quencher contained within the mastermix. At higher temperatures, fluorescence is very low as the majority of fluorescent reporters have been quenched. This change in fluorescence occurs at different temperatures for each amplicon, therefore, the different products can be distinguished based on temperature.

    179 samples were collected from the Leicester Royal Infirmary and tested by RT-PCR. The result of the multiplex assay were mostly in agreement with the results of the multiplex end-point PCR. The assay correctly identified 91.7% isolates tested. A summary of the statistical results can be found in Table 3. Seven very major errors and seven major errors were identified. Very major errors were defined as samples that showed as negative for ESBL genes by the RT-PCR assay, but positive by end-point PCR. Major errors were defined as samples that showed as positive for ESBL genes by the RT-PCR assay, but negative by end-point PCR.

    Summary of statistical analysis.
      RT-PCR Disk Diffusion
    Accuracy 91.71% (86.70-95.29) 87.36% (81.64 – 91.82)
    Sensitivity 94.87% (90.15-99.97) 96.82% (92.72 – 98.96)
    Specificity 72% (50.61-87.93) 28.00% (12.07 – 49.39)
    Positive likelihood ratio 3.39 (1.81-6.36) 1.34 (1.05 – 1.72)
    Negative likelihood ratio 0.07 (0.03-0.15) 0.11 (0.04 – 0.33)

    Interestingly, the real-time PCR assay picked up additional TEM genes in two of the isolates, which the end-point PCR had failed to. The NTC was assigned correctly as predicted.

    In comparison, the disk diffusion method correctly identified ESBL production in 87.36% of tested isolates. Whilst the sensitivity was slightly higher than the RT-PCR, the specificity was significantly lower (see Table 3). Eighteen very major errors and five major errors were identified.

    Limit of Detection

    The limit of detection for each of the set of primers CTX-M, TEM, OXA and SHV was 0.0004125ng/µl, 0.0242ng/µl, 0.000404ng/µl, and 0.000362 respectively. As TEM was not detected below 0.0242ng/µl, it is recommended that at least this amount of DNA is included in the test.

    Discussion

    Discussion

    Although other methods have been described for the detection of ESBLs, to our knowledge, this is the first study to accurately and rapidly describe a multiplex real-time PCR assay to detect ESBLs, based on amplicon melting temperatures, without the need for a high-resolution melting curve analysis. Whilst there are other chemistries applied in real-time PCR that do not require high-resolution melt-curve analysis for detection, such as Taqman, these tend to be far more expensive and require a higher level of user experience. 13 In this assay, the detection of products is based upon the melting temperature of amplicons, within each cycle. In the present study, 179 samples previously identified as ESBL-producers by disk diffusion methods, were tested using a Plexor®-based multiplex real-time PCR assay for the detection of 149 variants of the CTX-M, TEM, OXA and SHV genes in one amplification. The assay was able to correctly detect genes in 91.7% of the isolates in under 3 hours. In comparison, disk diffusion methods were able to correctly detect ESBL production in 87.4% of isolates. Whilst in this study, the disk diffusion method showed a slightly higher sensitivity than the RT-PCR method, this has not been seen in other studies. 1617 It has also been reported that clinical failures may occur, even when an isolate is negative phenotypically. 18 This may have been seen in this study, as there were eighteen cases where ESBL genes were detected by end-point PCR, but the isolate was negative phenotypically. This further advocates the use of genotypic detection.

    ESBL-producing Enterobacteriaceae are a global growing concern, especially when it comes to UTIs. Current susceptibility testing requires at least 24 hr., therefore it is common practice to treat with empirical antibiotic therapy, without full pathogen information. Treating in this way can lead to ineffective therapy, causing an increase in clinical symptoms, including the possibility of urosepsis and ascending infection. It is well known that empirical treatment with antibiotics increases the population of resistant pathogens. 19 Therefore, it is crucial that reliable, accurate and rapid detection methods of antibiotic resistance are available. In addition, prevalence studies are highly important for monitoring the spread and evolution of antibiotic resistance genes.

    Not only can the assay detect ESBL production in isolates in under 3 hours, it can also differentiate between the major classes of ESBL, aiding in surveillance studies. In addition, this assay did not require any laborious primer modifications and the results are easy to interpret, with no further analysis required. The results from this assay could lead to treatment escalation much more quickly than current methods. However, due to the low number of negative samples tested in this study, it is difficult to determine if treatment de-escalation could be concluded from the results of this assay. Nevertheless, due to the increased expense of PCR-based methods compared to current susceptibility testing methods, it is likely that only those patients who are suspected of having an ESBL producing UTI, such as patients who suffer from recurrent UTIs or those that are at higher risk (pregnant women, children, immunocompromised) would be tested. Therefore, the patient population tested in this study, represents the samples that would most likely be tested in practice. Until the negative likelihood ratio of this test can be more reliably proven, it is suggested that this test be used as an add-on to current testing in any patients that do not fall into the above criteria.

    In the future, more targets could be added to this multiplex assay, as long as they have a different amplicon melting temperature. This is achieved through primer design, as amplicon melting temperature is related to length and the ratio of CG/AT content. As technology improves, the melting temperature difference required between amplicons can decrease, further increasing the number of targets possible in the assay. We recommend that primers for other Carbapenamases and ampCs (other major antibiotic resistance genes) are added, to give this assay full breadth across the antibiotic resistance spectrum seen in UTIs.

    A multiplex Plexor®-based real-time PCR assay could provide a rapid, more sensitive, easy to interpret detection method, thereby helping to prevent the inappropriate use of antibiotics. It was found that this method could aid antibiotic susceptibility testing, if ESBL production is suspected. With further investigation this assay could form the basis of a high throughput kit that health services could use to detect ESBLS or other antibiotic resistance genes.

    Conclusion

    Affiliations:
    Affiliations: